Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Hims & Hers Health (NYSE: HIMS) Officer Sells 6,236 Shares at $27.86

Boughton Soleil sold 6,236 Hims & Hers Health (NYSE: HIMS) shares at $27.86 per share on 16 September 2026. The transaction involved the company’s Chief Legal Officer.

Vinay Lochav | 18 September 2026

Inhibrx Biosciences (NASDAQ: INBX) Director Buys 5,000 Shares at $100

Kayyem Jon Faiz bought 5,000 Inhibrx Biosciences shares at $100 each. For investors tracking insider ownership, the purchase leaves him with 429,360 shares, while the transaction represents about 1.2% of his resulting holding.Key HighlightsKayyem Jon Faiz’s purchase represented about 1.2% of his resulting Inhibrx …

Vinay Lochav | 18 September 2026

Altimmune (NASDAQ: ALT) Officer Exercises 24,000 Options at $0

Altimmune, Inc. (NASDAQ: ALT) is a biotechnology company. Richardson Linda M, the company’s Chief Commercial Officer, exercised options for 24,000 shares at $0 per share on September 16, 2026. She also forfeited 6,826 shares at $3.24 per share on the same date. That forfeited …

Vinay Lochav | 18 September 2026

ANAPTYSBIO (NASDAQ: ANAB) Exercises 1,300 Options at $0

ANAPTYSBIO, INC. (NASDAQ: ANAB) is a biotechnology company. Orwin John A exercised options for 1,300 ANAPTYSBIO shares at $0 on September 15, 2026, leaving him with 17,995 shares.

Vinay Lochav | 18 September 2026

Ascentage Pharma Posts 2026 Interim Report

Interim Report Covers Financial and Business Updates

Vinay Lochav | 18 September 2026

Beta Bionics (NASDAQ: BBNX) Chief Product Officer Sells 2,650 Shares at $22

Mensinger Mike, the company’s Chief Product Officer, sold 2,650 shares in the transaction. The disclosed price was $22 per share.

Vinay Lochav | 18 September 2026

Calidi Biotherapeutics (AMEX: CLDI) Offers 1.03M Shares at $1.17

Calidi Biotherapeutics, Inc. (AMEX: CLDI) is a biotechnology company. It is offering 1,025,640 shares of Common Stock at $1.17 per share, with estimated net proceeds of approximately $1.1 million after offering expenses.

Vinay Lochav | 18 September 2026

Caris Life Sciences (NASDAQ: CAI) Exercises 400,000 Options at $2.44

Caris Life Sciences, Inc. (NASDAQ: CAI) is a biotechnology company. Brille Brian J exercised options for 400,000 shares at $2.44 per share on 17 September 2026, alongside a separate sale of 400,000 shares at $30.33 per share.

Vinay Lochav | 18 September 2026

Celli James Receives 30,554 PSQ Holdings Shares at Up to $3.60

Celli James was awarded 30,554 shares in PSQ Holdings, Inc. (NYSE: PSQH) establishing a new insider position. The award carried prices ranging from $0 to $3.60 per share.

Vinay Lochav | 18 September 2026
Support

Hi! How can we help you today?

Loading…